New Directions for Women Inc Program for Women With Children

New Directions for Women Inc Program for Women With Children

Services:
Education and Counseling Services
• Group counseling
• Marital/couples counseling
• Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
• Family counseling
• Substance use disorder education
• Hepatitis education, counseling, or support
• Individual counseling
• Health education services other than HIV/AIDS or hepatitis
• HIV or AIDS education, counseling, or support

Type of Care

• Substance use treatment

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Type of Opioid Treatment

• Prescribes naltrexone
• Buprenorphine maintenance
• Accepts clients using MAT but prescribed elsewhere
• Prescribes buprenorphine

Age Groups Accepted

• Young Adults
• Adults

External Opioid Medications Source

• Other contracted prescribing entity
• In-network prescribing entity

Recovery Support Services

• Mentoring/peer support
• Self-help groups
• Housing services
• Assistance with obtaining social services

Facility Smoking Policy

• Smoking permitted in designated area

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Long-term residential
• Short-term residential
• Residential/24-hour residential

Ancillary Services

• Residential beds for clients’ children
• Case management service
• Social skills development
• Acupuncture
• Transportation assistance
• Domestic violence services, including family or partner
• Child care for clients’ children
• Suicide prevention services
• Integrated primary care services
• Mental health services

Pharmacotherapies

• Buprenorphine with naloxone
• Buprenorphine without naloxone
• Acamprosate (Campral®)
• Naltrexone (oral)
• Medication for mental disorders
• Non-nicotine smoking/tobacco cessation
• Buprenorphine (extended-release, injectable)
• Disulfiram
• Medications for Hepatitis C treatment
• Naltrexone (extended-release, injectable)

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity
• In-network prescribing entity

Treatment Approaches

• 12-step facilitation
• Motivational interviewing
• Relapse prevention
• Brief intervention
• Substance use disorder counseling
• Contingency management/motivational incentives
• Telemedicine/telehealth therapy
• Trauma-related counseling
• Cognitive behavioral therapy

License/Certification/Accreditation

• State Substance use treatment agency
• Commission on Accreditation of Rehabilitation Facilities (CARF)

Testing

• STD testing
• HIV testing
• TB screening
• Breathalyzer or blood alcohol testing
• Drug or alcohol urine screening

Special Programs/Groups Offered

• Clients who have experienced trauma
• Clients with co-occurring pain and substance use disorders
• Clients with co-occurring mental and substance use disorders
• Adult women

Transitional Services

• Naloxone and overdose education
• Aftercare/continuing care
• Outcome follow-up after discharge
• Discharge Planning

Assessment/Pre-treatment

• Screening for substance use
• Complete medical history/physical exam
• Outreach to persons in the community
• Comprehensive substance use assessment
• Screening for mental disorders
• Screening for tobacco use

Gender Accepted

• Female

Payment/Insurance/Funding Accepted

• Private health insurance
• Cash or self-payment
• IHS/Tribal/Urban (ITU) funds

Facility Vaping Policy

• Vaping permitted in designated area